— Know what they know.
Not Investment Advice
Also trades as: 2186.HK (HKSE) · $vol 10M

LYPHF Earnings

Luye Pharma Group Ltd.
1W: +0.0% 1M: +0.0% 3M: +32.3% YTD: -27.9% 1Y: +0.8% 3Y: -64.0%
$0.27
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · $1.1B mcap · 2.13B float · 0.0026% daily turnover · Short 100% of daily vol
Last Earnings 2026-08-30
EPS
¥0.00 (US$0.00)
▼ Miss -48.6%
Revenue
¥442M ($66M)
▼ Miss -5.0%

Estimate vs Actual

Earnings Surprise History

3/20
EPS Beats
3/20
Revenue Beats
15%
EPS Beat Rate
15%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2027-12-31 ¥0.19 ¥0.19 — ¥6,774,923,529 ¥6,764,930,347
2026-10-02 annual 2028-12-31 ¥0.24 ¥0.24 — ¥7,370,465,149 ¥7,359,593,528
2026-10-02 annual 2026-12-31 ¥0.18 ¥0.18 — ¥6,425,304,747 ¥6,415,827,261
2026-10-01 annual 2027-12-31 ¥0.19 ¥0.19 — ¥6,767,201,524 ¥6,774,923,529
2026-10-01 annual 2028-12-31 ¥0.24 ¥0.24 — ¥7,362,064,351 ¥7,370,465,149
2026-10-01 annual 2026-12-31 ¥0.18 ¥0.18 — ¥6,417,981,235 ¥6,425,304,747
2026-09-30 annual 2026-12-31 ¥0.18 ¥0.18 — ¥6,411,088,518 ¥6,417,981,235
2026-09-30 annual 2027-12-31 ¥0.19 ¥0.19 — ¥6,759,933,755 ¥6,767,201,524
2026-09-30 annual 2028-12-31 ¥0.24 ¥0.24 — ¥7,354,157,717 ¥7,362,064,351
2026-09-29 annual 2026-12-31 ¥0.18 ¥0.18 — ¥6,416,258,056 ¥6,411,088,518
2026-09-29 annual 2027-12-31 ¥0.19 ¥0.19 — ¥6,765,384,582 ¥6,759,933,755
2026-09-29 annual 2028-12-31 ¥0.24 ¥0.24 — ¥7,360,087,692 ¥7,354,157,717
2026-09-25 annual 2027-12-31 ¥0.19 ¥0.19 — ¥6,761,750,698 ¥6,765,384,582
2026-09-25 annual 2028-12-31 ¥0.24 ¥0.24 — ¥7,356,134,375 ¥7,360,087,692
2026-09-25 annual 2026-12-31 ¥0.18 ¥0.18 — ¥6,412,811,697 ¥6,416,258,056
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms